131 related articles for article (PubMed ID: 38746306)
1. Genetic Inactivation of the β1 adrenergic receptor prevents Cerebral Cavernous Malformations in zebrafish.
Li W; McCurdy S; Lopez-Ramirez MA; Lee HS
bioRxiv; 2024 May; ():. PubMed ID: 38746306
[TBL] [Abstract][Full Text] [Related]
2. Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.
Li W; Shenkar R; Detter MR; Moore T; Benavides C; Lightle R; Girard R; Hobson N; Cao Y; Li Y; Griffin E; Gallione C; Zabramski JM; Ginsberg MH; Marchuk DA; Awad IA
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33301422
[TBL] [Abstract][Full Text] [Related]
3. Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.
Li W; Tran V; Shaked I; Xue B; Moore T; Lightle R; Kleinfeld D; Awad IA; Ginsberg MH
Elife; 2021 May; 10():. PubMed ID: 34013885
[TBL] [Abstract][Full Text] [Related]
4. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
5. Novel Chronic Mouse Model of Cerebral Cavernous Malformations.
Cardoso C; Arnould M; De Luca C; Otten C; Abdelilah-Seyfried S; Heredia A; Leutenegger AL; Schwaninger M; Tournier-Lasserve E; Boulday G
Stroke; 2020 Apr; 51(4):1272-1278. PubMed ID: 31992178
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease.
Lai CC; Nelsen B; Frias-Anaya E; Gallego-Gutierrez H; Orecchioni M; Herrera V; Ortiz E; Sun H; Mesarwi OA; Ley K; Gongol B; Lopez-Ramirez MA
Circ Res; 2022 Nov; 131(11):909-925. PubMed ID: 36285625
[TBL] [Abstract][Full Text] [Related]
7. Bringing CCM into a dish: cell culture models for cerebral cavernous malformations.
Skowronek D; Pilz RA; Schwefel K; Much CD; Felbor U; Rath M
Med Genet; 2021 Sep; 33(3):251-259. PubMed ID: 38835694
[TBL] [Abstract][Full Text] [Related]
8. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.
Idiculla PS; Gurala D; Philipose J; Rajdev K; Patibandla P
Eur Neurol; 2020; 83(4):360-368. PubMed ID: 32731220
[TBL] [Abstract][Full Text] [Related]
9. Regulation of heart rate following genetic deletion of the ß1 adrenergic receptor in larval zebrafish.
Joyce W; Pan YK; Garvey K; Saxena V; Perry SF
Acta Physiol (Oxf); 2022 Aug; 235(4):e13849. PubMed ID: 35665450
[TBL] [Abstract][Full Text] [Related]
10. Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study.
Goldberg J; Jaeggi C; Schoeni D; Mordasini P; Raabe A; Bervini D
J Neurosurg; 2018 Jun; 130(6):1931-1936. PubMed ID: 29905510
[TBL] [Abstract][Full Text] [Related]
11. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
[TBL] [Abstract][Full Text] [Related]
12. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
[TBL] [Abstract][Full Text] [Related]
13. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
Yoruk B; Gillers BS; Chi NC; Scott IC
Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
[TBL] [Abstract][Full Text] [Related]
14. Novel Murine Models of Cerebral Cavernous Malformations.
Detter MR; Shenkar R; Benavides CR; Neilson CA; Moore T; Lightle R; Hobson N; Shen L; Cao Y; Girard R; Zhang D; Griffin E; Gallione CJ; Awad IA; Marchuk DA
Angiogenesis; 2020 Nov; 23(4):651-666. PubMed ID: 32710309
[TBL] [Abstract][Full Text] [Related]
15. Blood Flow Suppresses Vascular Anomalies in a Zebrafish Model of Cerebral Cavernous Malformations.
Rödel CJ; Otten C; Donat S; Lourenço M; Fischer D; Kuropka B; Paolini A; Freund C; Abdelilah-Seyfried S
Circ Res; 2019 Oct; 125(10):e43-e54. PubMed ID: 31495257
[TBL] [Abstract][Full Text] [Related]
16. Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.
Phillips CM; Stamatovic SM; Keep RF; Andjelkovic AV
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563390
[TBL] [Abstract][Full Text] [Related]
17. β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
McCurdy S; Lin J; Shenkar R; Moore T; Lightle R; Faurobert E; Lopez-Ramirez MA; Awad I; Ginsberg MH
FASEB J; 2022 Dec; 36(12):e22629. PubMed ID: 36349990
[TBL] [Abstract][Full Text] [Related]
18. Impaired retinoic acid signaling in cerebral cavernous malformations.
Grdseloff N; Boulday G; Rödel CJ; Otten C; Vannier DR; Cardoso C; Faurobert E; Dogra D; Tournier-Lasserve E; Abdelilah-Seyfried S
Sci Rep; 2023 Apr; 13(1):5572. PubMed ID: 37019926
[TBL] [Abstract][Full Text] [Related]
19. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.
Shi C; Shenkar R; Zeineddine HA; Girard R; Fam MD; Austin C; Moore T; Lightle R; Zhang L; Wu M; Cao Y; Gunel M; Louvi A; Rorrer A; Gallione C; Marchuk DA; Awad IA
J Neuroimmune Pharmacol; 2016 Jun; 11(2):369-77. PubMed ID: 27086141
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
